Common laboratory findings in NAFLD patients are hyperlipidemia, hyperglycemia, decreased insulin sensitivity, and mild or moderate elevations of liver enzymes, specifically, alanine and aspartate aminotransferases (ALT and AST) (9). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.